Promising research studies surrounding this compound, specifically the 120mg formulation referred to as ZPHC, indicate a impressive effect on physique reduction and associated metabolic illnesses . Experts anticipate that this combined compound, targeting both GLP-1 and GIP pathways , could represent a noteworthy advance in the approach of obesity